Erlotinib does not demonstrate increased survival in ovarian epithelial carcinomas
Image: PD Sisyphus 1. Patients with previously platinum-sensitive ovarian cancer showed no increase in progression-free survival or overall survival when ...
Image: PD Sisyphus 1. Patients with previously platinum-sensitive ovarian cancer showed no increase in progression-free survival or overall survival when ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.
© 2021 2 Minute Medicine, Inc. - Physician-written medical news.